These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9093039)

  • 21. Clinical features and outcomes of childhood hypertrophic cardiomyopathy: results from a national population-based study.
    Nugent AW; Daubeney PE; Chondros P; Carlin JB; Colan SD; Cheung M; Davis AM; Chow CW; Weintraub RG;
    Circulation; 2005 Aug; 112(9):1332-8. PubMed ID: 16116056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Normal pregnancy in a case of Noonan syndrome with hypertrophic cardiomyopathy.
    Yadav BS; Indurkar M; Bisarya BN
    J Assoc Physicians India; 1996 Jul; 44(7):494-5. PubMed ID: 9282616
    [No Abstract]   [Full Text] [Related]  

  • 23. [Analysis of clinical features of pregnant women with hypertrophic cardiomyopathy].
    Hu YH; Huang TT; Zhuang X; Lin JH
    Zhonghua Fu Chan Ke Za Zhi; 2013 Jul; 48(7):486-9. PubMed ID: 24284216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistently elevated nuchal translucency and the fetal heart.
    Vigneswaran TV; Homfray T; Allan LD; Simpson JM; Zidere V
    J Matern Fetal Neonatal Med; 2018 Sep; 31(18):2376-2380. PubMed ID: 28614966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac dysrhythmias in children with idiopathic dilated or hypertrophic cardiomyopathy.
    Müller G; Ulmer HE; Hagel KJ; Wolf D
    Pediatr Cardiol; 1995; 16(2):56-60. PubMed ID: 7540289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the prevalence, clinical features, and long-term outcomes of midventricular hypertrophy vs apical phenotype in patients with hypertrophic cardiomyopathy.
    Cai C; Duan FJ; Yang YJ; Guo XY; Liu YL; Liu YQ; Yan LR; Xu ZM; Zhao SH; Hua W; Li YS; Fan CM
    Can J Cardiol; 2014 Apr; 30(4):441-7. PubMed ID: 24468417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The natural history of Noonan syndrome: a long-term follow-up study.
    Shaw AC; Kalidas K; Crosby AH; Jeffery S; Patton MA
    Arch Dis Child; 2007 Feb; 92(2):128-32. PubMed ID: 16990350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between aetiology and left ventricular systolic dysfunction in hypertrophic cardiomyopathy.
    Rosmini S; Biagini E; O'Mahony C; Bulluck H; Ruozi N; Lopes LR; Guttmann O; Reant P; Quarta CC; Pantazis A; Tome-Esteban M; Mckenna WJ; Rapezzi C; Elliott PM
    Heart; 2017 Feb; 103(4):300-306. PubMed ID: 27798053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bilateral coronary artery dilatation and supravalvular pulmonary stenosis in a child with noonan syndrome.
    Uçar T; Atalay S; Tekin M; Tutar E
    Pediatr Cardiol; 2005; 26(6):848-50. PubMed ID: 16088418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy.
    Maron MS; Finley JJ; Bos JM; Hauser TH; Manning WJ; Haas TS; Lesser JR; Udelson JE; Ackerman MJ; Maron BJ
    Circulation; 2008 Oct; 118(15):1541-9. PubMed ID: 18809796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sudden cardiac arrest in the field in an 18-year-old male athlete with Noonan syndrome: case presentation and 5-year follow-up.
    Petrin Z; Soffer B; Daniels SJ
    Cardiol Young; 2019 Sep; 29(9):1214-1216. PubMed ID: 31378211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proximal left coronary artery occlusion in a 15-year-old boy with noonan syndrome and hypertrophic cardiomyopathy.
    Delhaas T; Mühler EG
    Pediatr Cardiol; 2003; 24(1):67-9. PubMed ID: 12574982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiomyopathy in childhood and adult life, with emphasis on hypertrophic cardiomyopathy.
    Landing BH; Recalde AL; Lawrence TY; Shankle WR
    Pathol Res Pract; 1994 Sep; 190(8):737-49. PubMed ID: 7831149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypertrophic Cardiomyopathy in Children, Adolescents, and Young Adults Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.
    Maron BJ; Rowin EJ; Casey SA; Lesser JR; Garberich RF; McGriff DM; Maron MS
    Circulation; 2016 Jan; 133(1):62-73. PubMed ID: 26518766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypertrophic cardiomyopathy: infants, children, and adolescents.
    Maskatia SA
    Congenit Heart Dis; 2012; 7(1):84-92. PubMed ID: 22222117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Long term follow-up results of 199 patients with hypertrophic cardiomyopathy].
    Li M; Wang QB; Cheng K
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Nov; 35(11):988-91. PubMed ID: 18269816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome of mildly symptomatic or asymptomatic obstructive hypertrophic cardiomyopathy: a long-term follow-up study.
    Sorajja P; Nishimura RA; Gersh BJ; Dearani JA; Hodge DO; Wiste HJ; Ommen SR
    J Am Coll Cardiol; 2009 Jul; 54(3):234-41. PubMed ID: 19589436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening.
    Basavarajaiah S; Wilson M; Whyte G; Shah A; McKenna W; Sharma S
    J Am Coll Cardiol; 2008 Mar; 51(10):1033-9. PubMed ID: 18325444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypertrophic cardiomyopathy in children.
    Moak JP; Kaski JP
    Heart; 2012 Jul; 98(14):1044-54. PubMed ID: 22591735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sudden cardiac death: investigation of the classical risk factors in a community-based hypertrophic cardiomyopathy cohort.
    Anastasakis A; Theopistou A; Rigopoulos A; Kotsiopoulou C; Georgopoulos S; Fragakis K; Sevdalis E; Stefanadis C
    Hellenic J Cardiol; 2013; 54(4):281-8. PubMed ID: 23912920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.